Herbal Dispatch Inc (QB) (LUFFF)

Herbal Dispatch Inc. Appoints Jason Spatafora as Strategic AdvisorJune 3, 2026 3:01 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - June 3, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a leading cannabis e-commerce and distribution platform, is pleased to announce the appointment of Jason Spatafora as a strategic advisor to the Company.The appointment comes as Herbal Dispatch continues its transformation into a scalable, technology-enabled cannabis distribution platform. The Company's proprietary technology infrastructure serves as the foundation for growth across its insured medical sales, international cannabis export operations and portfolio of house brands, creating operational leverage and enabling expansion across multiple markets and distribution channels.Mr. Spatafora, widely known within the cannabis investment community, is the Founder and Partner of Jefferson Equity Derivatives & Intelligence LLC ("JEDI LLC") and brings extensive experience in cannabis sector analysis, capital markets, corporate strategy, and public company advisory services. Mr. Spatafora has advised numerous public companies and has become a well-known voice within the North American cannabis investment community.In his role as strategic advisor, Mr. Spatafora will advise the Company on capital markets strategy, corporate positioning, strategic transactions, international partnership opportunities, and long-term value creation initiatives.Herbal Dispatch has recently undertaken a strategic evolution of its business, increasing its focus on higher-value and more scalable growth channels. The Company has continued expanding its veteran-focused medical cannabis platform, where direct-to-consumer medical revenue increased year-over-year, while also advancing its international export business and growing portfolio of proprietary brands.Philip Campbell, Chief Executive Officer of Herbal Dispatch, commented:"Mr. Spatafora brings a unique combination of capital markets expertise, industry knowledge, and strategic transaction experience. As we continue executing our growth strategy, we believe Jason's deep understanding of the cannabis sector and capital markets will provide valuable insight as we pursue new commercial opportunities, strategic partnerships, and initiatives to enhance shareholder value.""Herbal Dispatch is entering an exciting phase of growth. We are seeing increasing traction across our veteran channel, expanding international exports and growing adoption of our house brands. Mr. Spatafora's experience and network will strengthen our ability to execute on our growth strategy, pursue strategic opportunities, and create long-term shareholder value."Pursuant to the consulting agreement, and subject to Canadian Securities Exchange acceptance, the Company intends to grant JEDI LLC 500,000 stock options exercisable at the market price on the date of grant. The options will vest immediately, have a term of four years, and be governed by the Company's equity incentive plan and applicable securities laws. The grant remains subject to Canadian Securities Exchange acceptance.ABOUT HERBAL DISPATCH INC.Herbal Dispatch Inc. is a leading operator of cannabis e-commerce platforms in Canada, delivering quality medical and recreational products to discerning consumers at competitive prices. Its flagship marketplace has earned trust as a premier destination for exclusive access to small-batch craft cannabis and a wide selection of curated cannabis products. The Company is also actively expanding through exports to international markets, positioning it for sustained growth and new revenue opportunities. The Company's common shares trade on the Canadian Securities Exchange under the symbol "HERB".For further information:
Philip Campbell, CEO and Director
Email: IR @Scotty-432-2420CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATIONCertain statements in this news release, including statements or information containing terminology such as "anticipate", "believe", "intend", "expect", "estimate", "may", "could", "will", and similar expressions constitute "forward-looking statements" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, that address activities, events, or developments that the Company or a third party expect or anticipate will or may occur in the future, including the Company's future growth, results of operations, performance, and business prospects and opportunities are forward-looking statements.These forward-looking statements reflect the Company's current beliefs and are based on information currently available to the Company. These statements require the Company to make assumptions it believes are reasonable and are subject to inherent risks and uncertainties.Actual results and developments may differ materially from the anticipated results and developments discussed in the forward-looking statements as certain of these risks and uncertainties are beyond the Company's control. These risk factors are interdependent and the impact of any one risk or uncertainty on a particular forward-looking statement is not determinable. Consequently, all of the forward-looking statements made in this news release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected effects on the Company. These forward-looking statements are made as of the date of this news release. Except as required by applicable securities legislation, the Company assumes no obligation to update publicly or revise any forward-looking statements to reflect subsequent information, events, or circumstances.THE CANADIAN SECURITIES EXCHANGE (THE "CSE") HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS NEWS RELEASE. NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/299946 Original: Herbal Dispatch Inc. Appoints Jason Spatafora as Strategic Advisor

Herbal Dispatch Reports First Quarter 2026 Results and Provides Business UpdateJune 1, 2026 3:00 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - June 1, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a cannabis e-commerce and distribution platform, today reported its financial results for the three months ended March 31, 2026 and provided an update on the Company's strategic initiatives and operational progress.Strategic Transition UnderwayDuring the first quarter of 2026, Herbal Dispatch continued positioning its business toward higher-value, more scalable growth opportunities. The Company increased its focus on proprietary brands, insured medical patients, veterans, and international exports while reducing its reliance on lower-margin activities such as third-party brand sales and processing services.This strategic shift reflects management's belief that these channels offer stronger competitive advantages, larger addressable markets, greater customer retention, improved margin potential, and more recurring revenue characteristics. By concentrating resources on areas where the Company can create differentiated value, Herbal Dispatch is building a platform designed to support sustainable, global, long-term growth.While the quarter reflected the operational and financial impacts associated with this transition, many of these initiatives are already beginning to generate meaningful results.Positive Operational MomentumThe Company's veteran and insured-patient channel continued to gain momentum throughout the quarter. Direct-to-consumer medical revenue increased approximately 98% year-over-year, reflecting growing adoption of Herbal Dispatch's insurance-focused service model and expanding veteran patient base.The Company also continued investing in its portfolio of proprietary brands, including the expansion of existing brands and the launch of new product categories. Increasing brand ownership and product differentiation will enhance long-term profitability and strengthen customer loyalty. Herbal Dispatch now operates a portfolio of five proprietary cannabis brands comprising more than 40 SKUs across many of the industry's largest product categories, including flower, pre-rolls, edibles, vapes and concentrates. Internationally, Herbal Dispatch continued advancing its export strategy through the development of new customer relationships and regulated market opportunities. While export revenue recognized during the quarter was lower than the prior year, the Company subsequently completed multiple large-scale international shipments following quarter-end, including the largest export transaction in Company history. Since the beginning of 2026, the Company has completed international shipments totaling approximately 1,321 kilograms of medical cannabis, including a 298kg shipment destined for Germany, a 500kg export shipment to Europe, a subsequent 262kg European export shipment, as well as the inaugural export of medical cannabis gummies to Australia. These developments position the export business to become an increasingly important contributor to future revenue growth.Building a More Scalable PlatformIn parallel with its commercial initiatives, Herbal Dispatch continues investing in technology, automation, and artificial intelligence capabilities designed to improve operational efficiency, support data-driven decision making, enhance customer acquisition and retention, and create a highly scalable operating platform.The Company believes technology-enabled operations will become an increasingly important competitive advantage as it expands its medical, export, and branded product businesses.Management CommentaryPhilip Campbell, Chief Executive Officer of Herbal Dispatch, commented:"The first quarter was fundamentally about repositioning the business for where we see the greatest long-term opportunities. We made a decision to allocate resources toward veterans, exports, house brands, and other recurring revenue channels that we believe can generate significantly greater shareholder value over time.""While transitions of this nature can temporarily impact financial performance, we are already beginning to see the benefits emerge. The momentum we have experienced since quarter-end-including export activity, veteran onboarding, new export relationships, expanding house brands, and enhanced financing capabilities-gives us confidence that these strategic decisions are bearing fruit.""Our objective is to build a stronger, more scalable company with better margins, broader brand offerings, and multiple long-term growth engines. We believe the work completed during the first quarter has laid important groundwork toward achieving that objective."OutlookThe strategic initiatives implemented during the first quarter are already producing measurable results. Most notably, direct-to-consumer medical revenue increased year-over-year, growing from $383,912 in Q1 2025 to $761,375 in Q1 2026, reflecting the continued expansion of the Company's veteran and insured-patient platform. As part of the Company's strategic investments during the first quarter, Herbal Dispatch continued expanding its veteran and insured-patient platform, which has become one of the Company's fastest-growing business segments. The Company is currently onboarding approximately 50 new insured patients per month, reflecting growing demand for its insurance-focused service model and concierge-style patient support. Veteran patients generate approximately $6,000 in annual insured medical cannabis spending per patient, creating a highly recurring revenue stream with attractive long-term economics. The Company believes the investments made throughout the quarter are beginning to translate into accelerating patient growth and increasing revenue contribution from this channel.Since quarter-end, the Company has announced several international medical cannabis shipments over 700 kilograms, highlighting the growing momentum of its export platform and demonstrating the early impact of investments made during the first quarter.Looking ahead, the Company intends to continue executing on several key priorities, including:Continued expansion of its veteran and insured medical cannabis patient base;Further development of international export markets and long-term global commercial relationships;Increased penetration and distribution of the Company's growing portfolio of proprietary brands, now including five proprietary cannabis brands comprising more than 40 SKUs;Development and launch of a Medical Clinic to strengthen vertical integration and capture additional value within the patient journey;Enhancement of insurance-supported medical cannabis services and patient care infrastructure;Leveraging Export Development Canada-backed insurance and financing programs to support larger and more frequent international transactions, including $200,000 in export financing already secured, providing additional working capital to accelerate international growth opportunities; and,Continued investment in technology, automation, and AI initiatives designed to improve operational efficiency, enhance customer acquisition and retention, and support scalable decision-making across the business.With momentum building across veterans, exports, proprietary brands, and technology-driven initiatives, Herbal Dispatch is executing on a strategy designed to create a more scalable, higher-margin, and increasingly diversified cannabis business capable of delivering sustainable long-term growth.Financial ResultsThe Company's consolidated financial statements and management's discussion & analysis for the three months ended March 31, 2026 are available on the Company's profile on SEDAR+ at www.sedarplus.ca and will also be posted on the Company's website at www.herbaldispatch.com.ABOUT HERBAL DISPATCH INC.Herbal Dispatch Inc. is a leading operator of cannabis e-commerce platforms in Canada, delivering quality medical and recreational products to discerning consumers at competitive prices. Its flagship marketplace has earned trust as a premier destination for exclusive access to small-batch craft cannabis and a wide selection of curated cannabis products. The Company is also actively expanding through exports to international markets, positioning it for sustained growth and new revenue opportunities. The Company's common shares trade on the Canadian Securities Exchange under the symbol "HERB".For further information, contact: Philip Campbell, CEO and Director
Email: IR @Scotty-432-2420CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION Certain statements in this news release, including statements or information containing terminology such as "anticipate", "believe", "intend", "expect", "estimate", "may", "could", "will", and similar expressions constitute "forward-looking statements" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, that address activities, events, or developments that the Company or a third party expect or anticipate will or may occur in the future, including the Company's future growth, results of operations, performance, and business prospects and opportunities are forward-looking statements. These forward-looking statements reflect the Company's current beliefs and are based on information currently available to the Company. These statements require the Company to make assumptions it believes are reasonable and are subject to inherent risks and uncertainties. Actual results and developments may differ materially from the anticipated results and developments discussed in the forward-looking statements as certain of these risks and uncertainties are beyond the Company's control. These risk factors are interdependent and the impact of any one risk or uncertainty on a particular forward-looking statement is not determinable. Examples of forward-looking statements in this news release and the key assumptions and risk factors involved in such statements include, but are not limited to, future growth of sales related to veterans and the Company's insured medical cannabis patient base, international exports, and the Company's growing portfolio of proprietary brands. The successful execution of these initiatives to increase revenue is subject to a number of risks and uncertainties, including industry competition, regulatory approvals of anticipated export sales, and future customer demand for the Company's products, among others. Consequently, all of the forward-looking statements made in this news release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected effects on the Company. These forward-looking statements are made as of the date of this news release. Except as required by applicable securities legislation, the Company assumes no obligation to update publicly or revise any forward-looking statements to reflect subsequent information, events, or circumstances. THE CANADIAN SECURITIES EXCHANGE (THE "CSE") HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS NEWS RELEASE. NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/299594 Original: Herbal Dispatch Reports First Quarter 2026 Results and Provides Business Update

Herbal Dispatch Obtains Export Development Canada (EDC) Insurance to Support Accelerating International GrowthMay 26, 2026 5:01 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - May 26, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a cannabis e-commerce and distribution platform, is pleased to announce that it has obtained export credit insurance coverage through Export Development Canada ("EDC") in support of its growing international cannabis export business.The EDC insurance coverage becomes active on June 1, 2026, and is valid for an initial one-year term. Under the program, Herbal Dispatch may obtain insurance protection of up to $250,000 per qualified export transaction, with the coverage limit reusable throughout the policy term as additional insured transactions are completed.The EDC coverage is expected to provide protection against non-payment risk on qualified international receivables, enabling the Company to expand its global sales activities with increased confidence, enhanced financial flexibility, and improved working capital efficiency.The Company has also established financing relationships intended to support future export transactions under the EDC policy framework, which management believes will help facilitate larger and more frequent international shipments while maintaining disciplined risk management practices.Strengthening Export StrategyThe addition of EDC coverage represents another important operational milestone as Herbal Dispatch continues to expand its international distribution platform. The coverage is expected to:Support larger and more frequent international shipmentsSupport expansion into new jurisdictions with enhanced credit protectionImprove access to export financing and working capital solutionsMitigate counterparty risk associated with international buyersEnhance operational flexibility across the Company's export businessHerbal Dispatch has been actively expanding its export footprint, with existing customer relationships across multiple international markets including Australia, Portugal, Germany, Brazil, the Czech Republic, the United Kingdom, Switzerland, and Costa Rica."Securing EDC coverage is an important advancement for our international business and provides another layer of infrastructure as we continue expanding globally. The ability to insure export receivables while also accessing financing solutions tied to the policy meaningfully strengthens our export platform," Philip Campbell, CEO of Herbal Dispatch, stated. "We continue to see increasing international demand for premium Canadian cannabis products, particularly in regulated medical markets. With EDC support now in place, we believe Herbal Dispatch is increasingly well positioned to pursue larger export opportunities and continue expanding its international commercial relationships."OutlookThe Company expects the EDC policy to play an important role in its 2026 export strategy by supporting increased shipment volumes, broader geographic reach, and enhanced working capital management. Herbal Dispatch intends to continue pursuing additional international opportunities as global medical cannabis markets continue to mature.Herbal Dispatch will provide further updates as international export activities continue to expand.ABOUT HERBAL DISPATCH INC.Herbal Dispatch Inc. is a leading operator of cannabis e-commerce platforms in Canada, delivering quality medical and recreational products to discerning consumers at competitive prices. Its flagship marketplace has earned trust as a premier destination for exclusive access to small-batch craft cannabis and a wide selection of curated cannabis products. The Company is also actively expanding through exports to international markets, positioning it for sustained growth and new revenue opportunities. The Company's common shares trade on the Canadian Securities Exchange under the symbol "HERB".For further information, contact: Philip Campbell, CEO and Director
Email: IR @Scotty-432-2420CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION Certain statements in this news release, including statements or information containing terminology such as "anticipate", "believe", "intend", "expect", "estimate", "may", "could", "will", and similar expressions constitute "forward-looking statements" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, that address activities, events, or developments that the Company or a third party expect or anticipate will or may occur in the future, including the Company's future growth, results of operations, performance, and business prospects and opportunities are forward-looking statements. These forward-looking statements reflect the Company's current beliefs and are based on information currently available to the Company. These statements require the Company to make assumptions it believes are reasonable and are subject to inherent risks and uncertainties. Actual results and developments may differ materially from the anticipated results and developments discussed in the forward-looking statements as certain of these risks and uncertainties are beyond the Company's control. These risk factors are interdependent and the impact of any one risk or uncertainty on a particular forward-looking statement is not determinable. Examples of forward-looking statements in this news release and the key assumptions and risk factors involved in such statements include, but are not limited to, future growth of sales related to edibles both domestically and internationally, including additional follow-on shipments in 2026. The successful execution of these initiatives is subject to a number of risks and uncertainties, including industry competition, regulatory approvals of anticipated export sales, and future customer demand for the Company's products, among others. Consequently, all of the forward-looking statements made in this news release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected effects on the Company. These forward-looking statements are made as of the date of this news release. Except as required by applicable securities legislation, the Company assumes no obligation to update publicly or revise any forward-looking statements to reflect subsequent information, events, or circumstances. THE CANADIAN SECURITIES EXCHANGE (THE "CSE") HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS NEWS RELEASE. NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/298798 Original: Herbal Dispatch Obtains Export Development Canada (EDC) Insurance to Support Accelerating International Growth

Herbal Dispatch Completes Export of 261kg of Medical Cannabis to EuropeMay 21, 2026 5:01 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - May 21, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a cannabis e-commerce and distribution platform, is pleased to announce the successful completion of a 261-kilogram international medical cannabis export shipment to Europe.The shipment represents another significant milestone in the continued expansion of Herbal Dispatch's international export business and follows the Company's recently announced record-setting 500kg export shipment completed earlier this week.The Company believes continued demand from new international buyers reflects the increasing recognition of Canadian cannabis products within regulated global medical markets, particularly across Europe where demand for imported EU-GMP compliant cannabis products continues to rise.To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6253/298368_21cfccb0e4f55ae9_001full.jpgThe Company's international commercialization network now includes active relationships involving Australia, Portugal, Germany, Brazil, the Czech Republic, the United Kingdom, Europe, and Costa Rica."We continue to see growing inbound interest from international groups seeking reliable access to premium Canadian cannabis products" commented Philip Campbell, CEO of Herbal Dispatch. "Our focus remains on building diversified, long-term export channels across multiple regulated markets globally, and the continued expansion of our international customer base further validates the operational capability and long-term potential of our global export platform.The Company believes its export business represents a significant long-term opportunity to diversify revenue streams and participate in the continued globalization of the medical cannabis industry. Herbal Dispatch continues to advance its international strategy through various global partnerships, export infrastructure development, and expansion into regulated cannabis markets globally and will provide further updates as additional international shipments are completed.ABOUT HERBAL DISPATCH INC.Herbal Dispatch Inc. is a leading operator of cannabis e-commerce platforms in Canada, delivering quality medical and recreational products to discerning consumers at competitive prices. Its flagship marketplace has earned trust as a premier destination for exclusive access to small-batch craft cannabis and a wide selection of curated cannabis products. The Company is also actively expanding through exports to international markets, positioning it for sustained growth and new revenue opportunities. The Company's common shares trade on the Canadian Securities Exchange under the symbol "HERB".For further information:Philip Campbell, CEO and Director
Email: IR @Scotty-432-2420CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATIONCertain statements in this news release, including statements or information containing terminology such as "anticipate", "believe", "intend", "expect", "estimate", "may", "could", "will", and similar expressions constitute "forward-looking statements" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, that address activities, events, or developments that the Company or a third party expect or anticipate will or may occur in the future, including the Company's future growth, results of operations, performance, and business prospects and opportunities are forward-looking statements.These forward-looking statements reflect the Company's current beliefs and are based on information currently available to the Company. These statements require the Company to make assumptions it believes are reasonable and are subject to inherent risks and uncertainties.Actual results and developments may differ materially from the anticipated results and developments discussed in the forward-looking statements as certain of these risks and uncertainties are beyond the Company's control. These risk factors are interdependent and the impact of any one risk or uncertainty on a particular forward-looking statement is not determinable. Consequently, all of the forward-looking statements made in this news release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected effects on the Company. These forward-looking statements are made as of the date of this news release. Except as required by applicable securities legislation, the Company assumes no obligation to update publicly or revise any forward-looking statements to reflect subsequent information, events, or circumstances.THE CANADIAN SECURITIES EXCHANGE (THE "CSE") HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS NEWS RELEASE. NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/298368 Original: Herbal Dispatch Completes Export of 261kg of Medical Cannabis to Europe

Herbal Dispatch Completes Company Record 500kg Medical Cannabis Export Shipment to EuropeMay 19, 2026 5:01 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - May 19, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a cannabis e-commerce and distribution platform, is pleased to announce the successful completion of a 500-kilogram international medical cannabis export shipment to Europe.The shipment represents the largest international export shipment completed by Herbal Dispatch to date and marks another significant milestone in Herbal Dispatch's rapidly expanding international export business.This export further validates the Company's broader strategy of developing recurring supply relationships within regulated international medical cannabis markets, where demand for premium Canadian cannabis products continues to grow.Europe remains one of the most attractive global medical cannabis opportunities, supported by growing patient adoption, expanding regulatory frameworks, and increasing demand for EU-GMP compliant imported cannabis products.The Company notes that additional import permits are already in place under the current commercial relationship, with further shipments expected as demand continues to build.The shipment further strengthens Herbal Dispatch's growing international commercialization network, which now includes active relationships involving Australia, Portugal, Germany, Brazil, the Czech Republic, the United Kingdom, Europe, and Costa Rica."This shipment marks another major milestone for Herbal Dispatch and reflects the continued growth of our international export platform. Completing our largest export shipment to date demonstrates both the operational capability of the Company and the increasing international demand for premium Canadian cannabis products." Philip Campbell, CEO of Herbal Dispatch, commented. "As international markets continue to mature, we believe Herbal Dispatch is becoming increasingly well positioned to participate in the long-term growth of the global medical cannabis supply chain."Herbal Dispatch continues to advance its international strategy through strategic partnerships, export infrastructure development, and expansion into regulated medical cannabis markets globally. The Company believes its export business represents a significant long-term opportunity to diversify revenue streams and participate in the continued globalization of the medical cannabis industry.Herbal Dispatch will provide further updates as additional international shipments are completed.ABOUT HERBAL DISPATCH INC.Herbal Dispatch Inc. is a leading operator of cannabis e-commerce platforms in Canada, delivering quality medical and recreational products to discerning consumers at competitive prices. Its flagship marketplace has earned trust as a premier destination for exclusive access to small-batch craft cannabis and a wide selection of curated cannabis products. The Company is also actively expanding through exports to international markets, positioning it for sustained growth and new revenue opportunities. The Company's common shares trade on the Canadian Securities Exchange under the symbol "HERB".For further information:
Philip Campbell, CEO and Director
Email: IR @Scotty-432-2420CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATIONCertain statements in this news release, including statements or information containing terminology such as "anticipate", "believe", "intend", "expect", "estimate", "may", "could", "will", and similar expressions constitute "forward-looking statements" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, that address activities, events, or developments that the Company or a third party expect or anticipate will or may occur in the future, including the Company's future growth, results of operations, performance, and business prospects and opportunities are forward-looking statements.These forward-looking statements reflect the Company's current beliefs and are based on information currently available to the Company. These statements require the Company to make assumptions it believes are reasonable and are subject to inherent risks and uncertainties.Actual results and developments may differ materially from the anticipated results and developments discussed in the forward-looking statements as certain of these risks and uncertainties are beyond the Company's control. These risk factors are interdependent and the impact of any one risk or uncertainty on a particular forward-looking statement is not determinable. Consequently, all of the forward-looking statements made in this news release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected effects on the Company. These forward-looking statements are made as of the date of this news release. Except as required by applicable securities legislation, the Company assumes no obligation to update publicly or revise any forward-looking statements to reflect subsequent information, events, or circumstances.THE CANADIAN SECURITIES EXCHANGE (THE "CSE") HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS NEWS RELEASE. NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297926 Original: Herbal Dispatch Completes Company Record 500kg Medical Cannabis Export Shipment to Europe

Herbal Dispatch Secures EU-GMP Processing Partnership to Accelerate German and European Export GrowthMay 14, 2026 3:01 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - May 14, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a Canadian cannabis e-commerce and export platform, is pleased to announce that it has entered into an exclusive strategic supply agreement with a European Union Good Manufacturing Practice ("EU-GMP") licensed cannabis processor based in Portugal.The agreement establishes a long-term international commercialization framework through which Herbal Dispatch's Canadian cannabis products may be exported to the processor's EU-GMP-certified facility for processing, packaging and distribution into regulated European medical cannabis markets.Initial export shipments have already been successfully completed and the parties are now positioned to scale international distribution volumes as market demand continues to expand and European import processes become increasingly streamlined.Herbal Dispatch has established a growing international medical cannabis commercialization network spanning multiple regulated global markets including Australia, Portugal, Germany, Brazil, Czech Republic, United Kingdom, Switzerland, and Costa Rica, positioning the Company as an emerging participant within the global medical cannabis supply chain.In January 2026 Herbal Dispatch announced the completion of a 298kg export of medical cannabis destined for Germany's medical cannabis market through Portugal, marking a significant milestone in the Company's international expansion strategy. Following the success of this shipment, HD expanded its relationship with the Portugal-based group into a broader strategic export partnership designed to support scalable long-term distribution opportunities into Germany and additional regulated international medical cannabis markets.HD believes its Portugal-based export infrastructure and EU-GMP processing relationships provide the Company with a highly strategic gateway into the European medical cannabis market enabling efficient international commercialization, enhanced regulatory coordination, and scalable long-term export growth opportunities.Leveraging EU-GMP InfrastructureThrough this exclusive partnership, Herbal Dispatch is advancing its entry into key European jurisdictions, including Germany, one of the fastest-growing medical cannabis markets globally. Germany's pharmacy-based distribution model, combined with ongoing regulatory reform, continues to drive increasing demand for high-quality, EU-GMP compliant cannabis products.To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6253/297452_1fcd6147b467a9bc_001full.jpgEU-GMP certified processing capacity in Europe remains constrained relative to demand, creating a structural bottleneck for companies seeking compliant access to these markets. By partnering with an established EU-GMP processor, Herbal Dispatch is able to leverage existing pharmaceutical-grade infrastructure, significantly reducing capital requirements while accelerating time to market.In addition to dried cannabis flower, the Portuguese processor is capable of processing cannabis extracts and derivative products. This positions Herbal Dispatch to supply higher-value formats such as vape oils, hash, and other cannabis concentrates into regulated European markets, expanding both product breadth and margin profile.Regulatory Tailwinds Accelerating Export TimelinesThe Company also notes a near-term regulatory improvement in Portugal, with the transition to a digital import permit system for cannabis imports from Canada. This transition, expected to be implemented soon, is anticipated to reduce permit processing timelines from approximately six weeks to as little as seven business days. This development is expected to materially increase shipment velocity, improve working capital efficiency, and support the scaling of Herbal Dispatch's European export program."This relationship represents a meaningful step forward for our international strategy. Europe-particularly Germany-continues to be one of the most attractive medical cannabis markets globally, and this partnership provides a scalable pathway to participate in that growth," commented Philip Campbell, CEO of Herbal Dispatch. "With initial shipments now completed and permitting timelines expected to shorten materially, we believe we are entering a new phase where our European export business can operate in a more efficient and consistent manner."The Company intends to build on this relationship to increase shipment frequency, expand into additional EU markets, and broaden its product portfolio over time. Herbal Dispatch will provide further updates as export activities continue to scale.ABOUT HERBAL DISPATCH INC.Herbal Dispatch Inc. is a leading operator of cannabis e-commerce platforms in Canada, delivering quality medical and recreational products to discerning consumers at competitive prices. Its flagship marketplace has earned trust as a premier destination for exclusive access to small-batch craft cannabis and a wide selection of curated cannabis products. The Company is also actively expanding through exports to international markets, positioning it for sustained growth and new revenue opportunities. The Company's common shares trade on the Canadian Securities Exchange under the symbol "HERB".For further information:
Philip Campbell, CEO and Director
Email: IR @Scotty-432-2420CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATIONCertain statements in this news release, including statements or information containing terminology such as "anticipate", "believe", "intend", "expect", "estimate", "may", "could", "will", and similar expressions constitute "forward-looking statements" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, that address activities, events, or developments that the Company or a third party expect or anticipate will or may occur in the future, including the Company's future growth, results of operations, performance, and business prospects and opportunities are forward-looking statements.These forward-looking statements reflect the Company's current beliefs and are based on information currently available to the Company. These statements require the Company to make assumptions it believes are reasonable and are subject to inherent risks and uncertainties.Actual results and developments may differ materially from the anticipated results and developments discussed in the forward-looking statements as certain of these risks and uncertainties are beyond the Company's control. These risk factors are interdependent and the impact of any one risk or uncertainty on a particular forward-looking statement is not determinable. Consequently, all of the forward-looking statements made in this news release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected effects on the Company. These forward-looking statements are made as of the date of this news release. Except as required by applicable securities legislation, the Company assumes no obligation to update publicly or revise any forward-looking statements to reflect subsequent information, events, or circumstances.THE CANADIAN SECURITIES EXCHANGE (THE "CSE") HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS NEWS RELEASE. NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297452 Original: Herbal Dispatch Secures EU-GMP Processing Partnership to Accelerate German and European Export Growth

Herbal Dispatch Expands House of Brands Strategy with Launch of Northern Drip ExtractsMay 12, 2026 3:01 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company") is pleased to announce the launch of its new mid-to-premium cannabis extracts brand, Northern Drip, expanding the Company's presence in one of the fastest-growing segments of the Canadian cannabis market.Northern Drip represents Herbal Dispatch's fifth in-house brand launch, joining the Company's growing portfolio alongside Buzz, Happy Hour, NU, and Chomp.Designed for concentrate consumers and extract enthusiasts, Northern Drip offers a curated lineup of potent, terpene-rich products, including premium concentrates, hash, vape cartridges, and other extract-based formats. The brand is positioned to deliver high-quality cannabis experiences at accessible pricing, targeting growing consumer demand for high-THC and flavor-forward products.To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6253/297099_6132abc974843bf8_001full.jpgCannabis extracts continue to represent one of the largest and fastest-growing categories in the Canadian cannabis market, with inhaled extracts—including vape cartridges, hash, wax, and rosin-generating approximately $1.7 billion in Canadian retail sales in 2024/2025, representing approximately 31.1% of total cannabis sales nationally. 1Inspired by Canada's northern landscapes and craft cannabis culture, Northern Drip features products derived from premium genetics and produced using high-quality extraction methods focused on terpene preservation, potency, and consistency. The initial lineup includes solventless hash rosin, live resin concentrates, strain-specific vape cartridges, and other unique products for experienced consumers. Products within the Northern Drip line are expected to range from approximately 70% to 90%+ THC.Cannabis extracts continue to represent one of the fastest-growing and highest-margin categories in the Canadian cannabis market, driven by increasing consumer demand for potent, discreet, and convenience-oriented formats. Through Northern Drip, Herbal Dispatch intends to expand its footprint within this category while leveraging its existing medical, recreational, and wholesale distribution channels. The Northern Drip launch strengthens its broader house-brand strategy and supports long-term margin expansion through differentiated proprietary products."We are excited to launch Northern Drip as part of our continued expansion into high-growth cannabis categories. Extract consumers are increasingly looking for premium experiences, high potency, and authentic terpene profiles, and we believe Northern Drip is well positioned to meet that demand," commented Philip Campbell, CEO of Herbal Dispatch. "This launch also reflects our broader strategy of developing scalable in-house brands that strengthen customer loyalty, improve margins, and expand our product offering across both recreational and medical channels."Northern Drip products are available through Herbal Dispatch's online platforms and select wholesale partners across Canada. The Company expects to continue expanding the Northern Drip portfolio over time, including additional extract formats, infused products, and other derivative cannabis categories.Sources:
1:https://www150.statcan.gc.ca/n1/daily-quotidien/260305/cg-b004-eng.htm?utm_source=chatgpt.comABOUT HERBAL DISPATCH INC.Herbal Dispatch Inc. is a leading operator of cannabis e-commerce platforms in Canada, delivering quality medical and recreational products to discerning consumers at competitive prices. Its flagship marketplace has earned trust as a premier destination for exclusive access to small-batch craft cannabis and a wide selection of curated cannabis products. The Company is also actively expanding through exports to international markets, positioning it for sustained growth and new revenue opportunities. The Company's common shares trade on the Canadian Securities Exchange under the symbol "HERB".For further information:
Philip Campbell, CEO and Director
Email: IR @Scotty-432-2420CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATIONCertain statements in this news release, including statements or information containing terminology such as "anticipate", "believe", "intend", "expect", "estimate", "may", "could", "will", and similar expressions constitute "forward-looking statements" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, that address activities, events, or developments that the Company or a third party expect or anticipate will or may occur in the future, including the Company's future growth, results of operations, performance, and business prospects and opportunities are forward-looking statements.These forward-looking statements reflect the Company's current beliefs and are based on information currently available to the Company. These statements require the Company to make assumptions it believes are reasonable and are subject to inherent risks and uncertainties.Actual results and developments may differ materially from the anticipated results and developments discussed in the forward-looking statements as certain of these risks and uncertainties are beyond the Company's control. These risk factors are interdependent and the impact of any one risk or uncertainty on a particular forward-looking statement is not determinable. Consequently, all of the forward-looking statements made in this news release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected effects on the Company. These forward-looking statements are made as of the date of this news release. Except as required by applicable securities legislation, the Company assumes no obligation to update publicly or revise any forward-looking statements to reflect subsequent information, events, or circumstances.THE CANADIAN SECURITIES EXCHANGE (THE "CSE") HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS NEWS RELEASE. NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297099 Original: Herbal Dispatch Expands House of Brands Strategy with Launch of Northern Drip Extracts

Herbal Dispatch Reports Accelerating Veteran Customer Growth and Expansion of Insurance-Focused Service ChannelMay 7, 2026 7:00 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - May 7, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), is pleased to provide an update on the continued growth and expansion of its veteran-focused medical cannabis channel.The Company has experienced sustained acceleration in veteran customer acquisition, driven by targeted outreach, streamlined onboarding, and a dedicated service model tailored to the needs of veterans. Herbal Dispatch is currently onboarding hundreds of new veteran clients per month, demonstrating accelerating demand and continued optimization of its veteran acquisition and conversion strategy.This growth has resulted in an expanding base of active veteran clients and increasing recurring sales contribution from the insured medical channel. Veteran customers typically demonstrate strong retention and consistent monthly purchasing behaviour, supporting a predictable and scalable revenue stream.The veteran channel represents one of the most attractive segments within the Company's business model. On average, the Company sees approximately $7,000 in annual insured spend per client. Combined with 50%+ gross margins and high customer retention rates, results in a highly scalable recurring revenue stream. The Company continues to invest in this channel as a priority growth area, given its strong lifetime value characteristics and efficient customer acquisition profile.In the first quarter of 2026, the Company increased veteran registrations by approximately 400% compared to all of 2025. Notably, total insured cannabis gross sales revenue for the full year 2025 was $675,000, nearly matched in the first fourth months of 2026 alone-implying a current annualized run rate of ~$2.23 million. This run rate is expected to continue to increase over 2026 as the Company builds out its veteran marketing and sales platform. Herbal Dispatch Insured Medical Cannabis Sales Snapshot
2025Q1 2026Current (Apr 2026)Q2 2026 (Est.)Gross sales$675,000$438,000$186,000~$850,000Annualized sales$675,000$1.75M~$2.23M~$3.5M-$4M Dedicated Veteran Channel & Insurance-Focused ServiceHerbal Dispatch operates a dedicated channel for veterans, offering bespoke services designed to simplify access to medical cannabis, with a particular focus on insurance-supported care, including programs administered through Blue Cross.The Company provides a concierge-style service, where orders are curated for clients based on individual preferences, medical needs, and coverage parameters. This model is designed to reduce friction for patients navigating insurance processes, and create alignment with eligible coverage, ensuring each client fully utilizes their monthly insurance allotment while optimizing outcomes and consistency of care.Veterans Affairs Canada Medical Cannabis Program GrowthTo view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6253/296403_44246674a4297b22_001full.jpgStrategic Importance of Veteran ChannelThe veteran segment remains a core growth pillar for the Company. Canada had approximately 461,000 veterans in 2021 according to Statistics Canada, with broader estimates suggesting the current total veteran population exceeds 600,000 individuals1. A significant portion of this population suffers from conditions widely recognized as appropriate for medical cannabis treatment, including chronic pain, representing a substantial addressable patient base.Government-supported insurance programs have historically funded a substantial portion of medical cannabis access for veterans, with total reimbursements under Veterans Affairs Canada programs-administered through Medavie Blue Cross-totaling $244.6 million in 2025 and $191.7 million in 2024, representing a current annual run-rate of approximately $230-$245 million 2. Recent reporting indicates that approximately 31,000+ veterans are currently participating in the program 3, underscoring both the scale and continued growth of this channel.The Company's integrated model-combining product access, administrative support, and insurance alignment-positions it to capture market share within this underserved segment.Operational Scaling"We are seeing veteran sales gain real momentum and begin to scale in a compounding way," said Philip Campbell, CEO of Herbal Dispatch. "As a result of ongoing investment in our medical platform, we are now seeing accelerating onboarding, strong retention, and increasing utilization per patient, which is driving consistent growth and setting the stage for meaningful long-term expansion of this channel."To support continued growth, Herbal Dispatch has expanded its customer service capabilities, enhanced internal systems for patient intake and insurance coordination, and strengthened relationships with prescribing clinics and healthcare providers.OutlookHerbal Dispatch expects the veteran channel to remain a key driver of revenue growth. The Company will continue to invest in this segment through targeted acquisition strategies and ongoing enhancement of its insurance-supported, concierge-driven service model.Sources: 1 https://www12.statcan.gc.ca/census-recensement/2021/ref/98-20-0002/982000022021001-eng.cfm2 https://www.veterans.gc.ca/en/about-vac/reports-policies-and-legislation/departmental-reports/cannabis-medical-purposes3 https://www.veterans.gc.ca/en/contact-us/help/faqs/cannabis-medical-purposes-revised-reimbursement-policyABOUT HERBAL DISPATCH INC.Herbal Dispatch Inc. is a leading operator of cannabis e-commerce platforms in Canada, delivering quality medical and recreational products to discerning consumers at competitive prices. Its flagship marketplace has earned trust as a premier destination for exclusive access to small-batch craft cannabis and a wide selection of curated cannabis products. The Company is also actively expanding through exports to international markets, positioning it for sustained growth and new revenue opportunities. The Company's common shares trade on the Canadian Securities Exchange under the symbol "HERB".For further information contact: Philip Campbell, CEO and Director
Email: IR @Scotty-432-2420CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION Certain statements in this news release, including statements or information containing terminology such as "anticipate", "believe", "intend", "expect", "estimate", "may", "could", "will", and similar expressions constitute "forward-looking statements" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, that address activities, events, or developments that the Company or a third party expect or anticipate will or may occur in the future, including the Company's future growth, results of operations, performance, and business prospects and opportunities are forward-looking statements. These forward-looking statements reflect the Company's current beliefs and are based on information currently available to the Company. These statements require the Company to make assumptions it believes are reasonable and are subject to inherent risks and uncertainties. Actual results and developments may differ materially from the anticipated results and developments discussed in the forward-looking statements as certain of these risks and uncertainties are beyond the Company's control. These risk factors are interdependent and the impact of any one risk or uncertainty on a particular forward-looking statement is not determinable. Examples of forward-looking statements in this news release and the key assumptions and risk factors involved in such statements include, but are not limited to, the anticipated growth of the veteran sales channel for Herbal Dispatch. The successful execution of these initiatives is subject to a number of risks and uncertainties, including industry competition, future benefit coverages by insurance providers, and future customer demand for the Company's products, among others. Consequently, all of the forward-looking statements made in this news release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected effects on the Company. These forward-looking statements are made as of the date of this news release. Except as required by applicable securities legislation, the Company assumes no obligation to update publicly or revise any forward-looking statements to reflect subsequent information, events, or circumstances. THE CANADIAN SECURITIES EXCHANGE (THE "CSE") HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS NEWS RELEASE. NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/296403 Original: Herbal Dispatch Reports Accelerating Veteran Customer Growth and Expansion of Insurance-Focused Service Channel

Herbal Dispatch Launches Next-Generation E-Commerce Platform, Targeting High-Growth $245 Million Insured Medical Cannabis SegmentMay 5, 2026 3:01 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - May 5, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a cannabis e-commerce and distribution platform, is pleased to announce the launch of the upgraded HeroDispatch.com, alongside significant enhancements to HerbalDispatch.com for standard medical patients.These upgraded platforms are designed to position Herbal Dispatch as a preferred partner for both patients and clinic operators nationwide, delivering improvements across integration, user experience, and operational scalability.Platform AdvantagesThe enhanced HeroDispatch platform streamlines clinic workflows and elevates the patient experience, creating a more efficient and scalable medical channel. Herbal Dispatch operates a portfolio of Shopify-based e-commerce platforms tailored to distinct customer segments, enabling the Company to optimize user experience, marketing, and product offerings while leveraging a shared backend infrastructure. HeroDispatch.com serves as the Company's dedicated platform for veterans and insured medical patients, supporting insurance-backed purchasing, and clinic integration to drive higher conversion, retention, and lifetime value within this segment. The veteran channel delivers strong unit economics for the Company, with gross margins exceeding 50%, reinforcing its position as a highly scalable and high-quality recurring revenue stream.To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6253/295902_2976eaf0d4913b17_001full.jpgFor customers, the platform delivers a simplified and personalized experience through curated product selection, transparent pricing, concierge-style support, and seamless direct insurance billing. These features support strong patient satisfaction, high retention, and recurring revenue.Strategic Market OpportunityThe upgraded HeroDispatch.com targets Canada's large and underpenetrated insured medical cannabis segment for veterans and fully insured patients-a market driven primarily by Veterans Affairs Canada reimbursements of approximately $245 million annually based on recent reporting, with reimbursements expected to continue to grow into 2026.Canada currently has approximately 600,000+ veterans, with research from Statistics Canada indicating that Chronic Pain is one of the highest causes of disability or activity limitation for Veterans. Chronic pain is one of the most common conditions where medical cannabis is used, however, only approximately 30,000 veterans are currently participating in reimbursement programs, indicating significant underpenetration and a substantial opportunity to expand adoption within this segment.Despite recent policy adjustments in Budget 2025, the Company continues to see resilient demand in this segment, which is characterized by high retention and recurring purchasing. Herbal Dispatch believes this positions HeroDispatch as a leading platform to capture share in one of the most attractive verticals in Canadian cannabis.To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6253/295902_2976eaf0d4913b17_002full.jpgThe Company believes HeroDispatch is well positioned to become a leading platform for insured medical cannabis patients in Canada, supported by its integrated technology, patient-centric model, and expanding national footprint.Future InitiativesIn parallel, Herbal Dispatch is evaluating the launch of its own medical clinic to enhance service delivery, accelerate onboarding, and capture additional value across the patient lifecycle. The Company currently incurs recurring third-party costs related to initial patient registration and annual renewals; internalizing these functions is expected to materially increase per-patient margin contribution while improving conversion, retention, and overall operating leverage."HeroDispatch.com represents a meaningful advancement in how we provide medical cannabis to our customers. We have focused on eliminating friction for clinics while delivering a more seamless and personalized experience for patients. The strength of our model is reflected in our retention and ongoing patient engagement, and we continue to see increasing adoption from both patients and healthcare providers," stated Philip Campbell, CEO of Herbal Dispatch. "From a business standpoint, this channel is highly efficient, with strong margins and recurring revenue that support long-term scalability and predictable growth."ABOUT HERBAL DISPATCH INC.Herbal Dispatch Inc. is a leading operator of cannabis e-commerce platforms in Canada, delivering quality medical and recreational products to discerning consumers at competitive prices. Its flagship marketplace has earned trust as a premier destination for exclusive access to small-batch craft cannabis and a wide selection of curated cannabis products. The Company is also actively expanding through exports to international markets, positioning it for sustained growth and new revenue opportunities. The Company's common shares trade on the Canadian Securities Exchange under the symbol "HERB".For further information:
Philip Campbell, CEO and Director
Email: IR @Scotty-432-2420CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATIONCertain statements in this news release, including statements or information containing terminology such as "anticipate", "believe", "intend", "expect", "estimate", "may", "could", "will", and similar expressions constitute "forward-looking statements" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, that address activities, events, or developments that the Company or a third party expect or anticipate will or may occur in the future, including the Company's future growth, results of operations, performance, and business prospects and opportunities are forward-looking statements.These forward-looking statements reflect the Company's current beliefs and are based on information currently available to the Company. These statements require the Company to make assumptions it believes are reasonable and are subject to inherent risks and uncertainties.Actual results and developments may differ materially from the anticipated results and developments discussed in the forward-looking statements as certain of these risks and uncertainties are beyond the Company's control. These risk factors are interdependent and the impact of any one risk or uncertainty on a particular forward-looking statement is not determinable. Examples of forward-looking statements in this news release and the key assumptions and risk factors involved in such statements include, but are not limited to, future growth of sales related to the veterans channel and achieving targeted gross margins from those sales. The successful execution of these initiatives is subject to a number of risks and uncertainties, including industry competition and future customer demand for the Company's products by veterans and insured medical patients, among others.Consequently, all of the forward-looking statements made in this news release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected effects on the Company. These forward-looking statements are made as of the date of this news release. Except as required by applicable securities legislation, the Company assumes no obligation to update publicly or revise any forward-looking statements to reflect subsequent information, events, or circumstances.THE CANADIAN SECURITIES EXCHANGE (THE "CSE") HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS NEWS RELEASE. NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/295902 Original: Herbal Dispatch Launches Next-Generation E-Commerce Platform, Targeting High-Growth $245 Million Insured Medical Cannabis Segment

Herbal Dispatch Completes First International Gummy Export, Generates $350,000 in Revenue and Advances Global Edibles StrategyApril 30, 2026 8:00 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - April 30, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), today announces the successful completion of its first export of medical cannabis gummies to Australia, generating approximately $350,000 in revenue and marking a significant milestone in the Company's international growth strategy.The export reflects accelerating global demand for regulated cannabis edibles and reinforces Herbal Dispatch's ability to deliver compliant, high-quality products into international markets. The customer for this shipment is a top three global cannabis company, further validating Herbal Dispatch's positioning as a trusted supply partner in the international medical cannabis ecosystem."We are pleased to have successfully completed the first tranche of our export of premium cannabis gummies to Australia," said Philip Campbell, CEO of Herbal Dispatch "This milestone highlights both the strength of our product offering and our ability to execute in regulated international markets. We view this as an important step in scaling a high-margin export channel and establishing recurring international revenue streams."The shipped products consist of Herbal Dispatch's medical cannabis gummies, produced in compliance with Canadian federal regulations and applicable GMP standards. Based on current demand and partner engagement, the Company anticipates additional follow-on shipments in 2026, subject to regulatory approvals and market conditions. The Company currently maintains active export relationships across multiple international markets, including Australia, Portugal, Germany (most recently in January 2026), Brazil, Czech Republic, United Kingdom, Switzerland, and Costa Rica, reflecting the continued expansion of its global distribution footprint.To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6253/295081_herb2.jpgExpanding Edibles StrategyIn parallel with its international initiatives, Herbal Dispatch is actively expanding its gummies and edibles offering domestically under the Chomp brand, responding to strong and growing consumer demand across both medical and recreational channels. The Company views edibles as a key category for long-term growth, driven by consumer preference for convenient, dose-controlled formats and increasing adoption across global markets.Herbal Dispatch's integrated platform—spanning product development, distribution, and direct-to-consumer channels—positions the Company to capture share in the expanding edibles segment both in Canada and internationally.This initial export shipment represents a meaningful step forward in Herbal Dispatch's broader strategy to scale its international footprint while simultaneously strengthening its domestic product portfolio. The Company continues to build a diversified revenue base across high-growth categories and jurisdictions, with a focus on margin expansion and sustainable growth.Herbal Dispatch will provide further updates as additional shipments progress.To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6253/295081_herb-1.jpgABOUT HERBAL DISPATCH INC.Herbal Dispatch Inc. is a leading operator of cannabis e-commerce platforms in Canada, delivering quality medical and recreational products to discerning consumers at competitive prices. Its flagship marketplace has earned trust as a premier destination for exclusive access to small-batch craft cannabis and a wide selection of curated cannabis products. The Company is also actively expanding through exports to international markets, positioning it for sustained growth and new revenue opportunities. The Company's common shares trade on the Canadian Securities Exchange under the symbol "HERB".For further information, contact: Philip Campbell, CEO and Director
Email: IR @Scotty-432-2420CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION Certain statements in this news release, including statements or information containing terminology such as "anticipate", "believe", "intend", "expect", "estimate", "may", "could", "will", and similar expressions constitute "forward-looking statements" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, that address activities, events, or developments that the Company or a third party expect or anticipate will or may occur in the future, including the Company's future growth, results of operations, performance, and business prospects and opportunities are forward-looking statements. These forward-looking statements reflect the Company's current beliefs and are based on information currently available to the Company. These statements require the Company to make assumptions it believes are reasonable and are subject to inherent risks and uncertainties. Actual results and developments may differ materially from the anticipated results and developments discussed in the forward-looking statements as certain of these risks and uncertainties are beyond the Company's control. These risk factors are interdependent and the impact of any one risk or uncertainty on a particular forward-looking statement is not determinable. Examples of forward-looking statements in this news release and the key assumptions and risk factors involved in such statements include, but are not limited to, future growth of sales related to edibles both domestically and internationally, including additional follow-on shipments in 2026. The successful execution of these initiatives is subject to a number of risks and uncertainties, including industry competition, regulatory approvals of anticipated export sales, and future customer demand for the Company's products, among others. Consequently, all of the forward-looking statements made in this news release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected effects on the Company. These forward-looking statements are made as of the date of this news release. Except as required by applicable securities legislation, the Company assumes no obligation to update publicly or revise any forward-looking statements to reflect subsequent information, events, or circumstances. THE CANADIAN SECURITIES EXCHANGE (THE "CSE") HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS NEWS RELEASE. NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/295081
Original: Herbal Dispatch Completes First International Gummy Export, Generates $350,000 in Revenue and Advances Global Edibles Strategy

Herbal Dispatch Provides Market Update on Launch of First Edible Brand: Chomp EdiblesApril 28, 2026 3:01 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - April 28, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a cannabis e-commerce and distribution platform, today announced the launch of its first dedicated edibles brand, Chomp Edibles ("Chomp"), marking a strategic expansion into one of the fastest-growing segments of the Canadian cannabis market.Chomp represents a focused push into the "accessible premium" category—delivering high-quality, craft-inspired edibles at a competitive price point designed to appeal to both new and experienced consumers. The brand is built to capture increasing demand for consistent, flavour-forward, and precisely dosed cannabis products.The initial Chomp lineup includes the following flavours: Grape, Cherry Coke, Cherry, Freshly Squeezed Orange, and Blueberry, each developed using high-quality ingredients and designed to deliver a differentiated consumer experience.The product line has been structured to align with evolving consumer preferences and regulatory developments, offering multiple dosing and pack configurations:10mg THC (single unit)5mg THC per unit (2-pack format)10mg THC x 10 (master pack)10mg THC x 20 (master pack)The introduction of larger-format "master packs" reflects recent regulatory changes and is intended to improve consumer value, increase basket size, and enhance purchasing convenience while maintaining full compliance.Market OpportunityEdibles continue to gain significant traction within Canada's legal cannabis market. In Q1 2025, edibles accounted for approximately 26% of total packaged units sold nationally, making it the second-largest category behind dried flower. The broader Canadian cannabis market reached approximately $5.2 billion in annual sales and is projected to continue expanding, with edibles representing one of the fastest-growing segments 1.This shift reflects changing consumer preferences toward discreet, convenient, and precisely dosed formats, reinforcing the strategic importance of the category.Management CommentaryTo view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6253/294506_2fdced0ea4b4a9d5_001full.jpg"We are excited to launch Chomp Edibles as our first dedicated brand in this high-growth category," said Philip Campbell, CEO of Herbal Dispatch. "Edibles-and gummies in particular-are rapidly becoming a dominant category in both medical and recreational markets. With strong domestic traction and growing consumer demand, we believe Herbal Dispatch is exceptionally well positioned to scale this segment aggressively and capture meaningful market share.""Chomp allows us to capture a larger share of the edibles market while leveraging our existing platform, distribution capabilities, and customer relationships. We see this as a key pillar of our growth strategy moving forward."Distribution and ExpansionChomp Edibles is available through Herbal Dispatch's medical and veteran platforms, as well as select wholesale channels across Canada, providing broad and growing national distribution. Medical patients can access Chomp through the Company's platform, which offers personalized support and streamlined insurance-backed purchasing, reinforcing Herbal Dispatch's position as a leading provider of accessible, patient-focused cannabis solutions.This launch represents a strategic step in Herbal Dispatch's continued evolution as a platform-driven cannabis company, focused on capturing high-growth categories, expanding margins, and scaling both domestically and internationally.Herbal Dispatch will provide further updates as product expansion and additional export opportunities progress.References:https://stratcann.com/news/canadian-cannabis-sales-and-inventory-q1-2025-market-share-shifts-and-inventory-increases/Graph: https://stratcann.com/news/canadian-cannabis-sales-and-inventory-q1-2025-market-share-shifts-and-inventory-increases/About Herbal Dispatch Inc.Herbal Dispatch Inc. is a leading operator of cannabis e-commerce platforms in Canada, delivering quality medical and recreational products to discerning consumers at competitive prices. Its flagship marketplace has earned trust as a premier destination for exclusive access to small-batch craft cannabis and a wide selection of curated cannabis products. The Company is also actively expanding through exports to international markets, positioning it for sustained growth and new revenue opportunities. The Company's common shares trade on the Canadian Securities Exchange under the symbol "HERB".For further information:
Philip Campbell, CEO and Director
Email: IR @Scotty-432-2420CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATIONCertain statements in this news release, including statements or information containing terminology such as "anticipate", "believe", "intend", "expect", "estimate", "may", "could", "will", and similar expressions constitute "forward-looking statements" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, that address activities, events, or developments that the Company or a third party expect or anticipate will or may occur in the future, including the Company's future growth, results of operations, performance, and business prospects and opportunities are forward-looking statements. These forward-looking statements reflect the Company's current beliefs and are based on information currently available to the Company. These statements require the Company to make assumptions it believes are reasonable and are subject to inherent risks and uncertainties.Actual results and developments may differ materially from the anticipated results and developments discussed in the forward-looking statements as certain of these risks and uncertainties are beyond the Company's control. These risk factors are interdependent and the impact of any one risk or uncertainty on a particular forward-looking statement is not determinable. Examples of forward-looking statements in this news release and the key assumptions and risk factors involved in such statements include, but are not limited to, future growth of sales related to edibles both domestically and internationally, including from the newly launched Chomp Edibles brand. The successful execution of these initiatives is subject to a number of risks and uncertainties, including industry competition, regulatory approvals of anticipated export sales, and future customer demand for the Company's products, among others. Consequently, all of the forward-looking statements made in this news release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected effects on the Company. These forward-looking statements are made as of the date of this news release. Except as required by applicable securities legislation, the Company assumes no obligation to update publicly or revise any forward-looking statements to reflect subsequent information, events, or circumstances.THE CANADIAN SECURITIES EXCHANGE (THE "CSE") HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS NEWS RELEASE. NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/294506
Original: Herbal Dispatch Provides Market Update on Launch of First Edible Brand: Chomp Edibles

Herbal Dispatch Advances U.S. Strategy amid Historic Cannabis Rescheduling ShiftApril 27, 2026 3:01 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - April 27, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), provides an update on recent regulatory developments in the United States relating to the proposed rescheduling of cannabis under the Controlled Substances Act.The U.S. Department of Health and Human Services has recommended that cannabis be reclassified from Schedule I to Schedule III, a move that, if finalized by the Drug Enforcement Administration, would represent a transformational shift for the U.S. cannabis industry and a major catalyst for capital inflows, institutional participation, and sector re-rating.Accelerating U.S. StrategyHerbal Dispatch is actively advancing its U.S. strategy in response to these developments, positioning the Company to capitalize on what management believes is a generational inflection point in the cannabis sector.The Company is evaluating multiple pathways to enter the U.S. market, with a primary focus on medical cannabis channels, where Herbal Dispatch has established expertise. The Company's capabilities in patient acquisition, insurance-supported programs (including veteran-focused services), and direct-to-consumer medical distribution are highly aligned with emerging U.S. medical frameworks.Management is actively assessing:Strategic partnerships and joint venturesPlatform-led distribution opportunitiesEntry into regulated medical channels as they expandHerbal Dispatch's asset-light, technology-enabled model is designed to enable rapid execution with limited capital intensity, allowing the Company to scale efficiently as opportunities materialize.Capital Markets PositioningWith its OTCQB listing (LUFFF) and recent DTC eligibility, Herbal Dispatch is positioned to benefit from increased U.S. investor participation as the sector gains renewed attention. The Company expects these developments to drive improved liquidity, broader investor reach, and enhanced valuation visibility.Market ContextRescheduling to Schedule III is expected to:Eliminate the impact of Internal Revenue Code Section 280E, significantly improving operator profitabilityImprove access to institutional capital and financial servicesAccelerate consolidation and strategic investment across the sectorThese changes are widely expected to catalyze a re-rating of cannabis equities and expand participation from both institutional and retail investors.OutlookHerbal Dispatch believes the proposed rescheduling represents a pivotal moment for the global cannabis industry. The Company is proactively positioning to participate in the next phase of industry growth, with a clear focus on expanding into U.S. medical cannabis channels while continuing to scale its Canadian operations.As regulatory clarity improves, Herbal Dispatch expects to advance its U.S. initiatives and will provide updates as strategic opportunities are executed.ABOUT HERBAL DISPATCH INC.Herbal Dispatch Inc. is a leading operator of cannabis e-commerce platforms in Canada, delivering quality medical and recreational products to discerning consumers at competitive prices. Its flagship marketplace has earned trust as a premier destination for exclusive access to small-batch craft cannabis and a wide selection of curated cannabis products. The Company is also actively expanding through exports to international markets, positioning it for sustained growth and new revenue opportunities. The Company's common shares trade on the Canadian Securities Exchange under the symbol "HERB".For further information contact: Philip Campbell, CEO and Director
Email: IR @Scotty-432-2420CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION Certain statements in this news release, including statements or information containing terminology such as "anticipate", "believe", "intend", "expect", "estimate", "may", "could", "will", and similar expressions constitute "forward-looking statements" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, that address activities, events, or developments that the Company or a third party expect or anticipate will or may occur in the future, including the Company's future growth, results of operations, performance, and business prospects and opportunities are forward-looking statements. These forward-looking statements reflect the Company's current beliefs and are based on information currently available to the Company. These statements require the Company to make assumptions it believes are reasonable and are subject to inherent risks and uncertainties. Actual results and developments may differ materially from the anticipated results and developments discussed in the forward-looking statements as certain of these risks and uncertainties are beyond the Company's control. These risk factors are interdependent and the impact of any one risk or uncertainty on a particular forward-looking statement is not determinable. Examples of forward-looking statements in this news release and the key assumptions and risk factors involved in such statements include, but are not limited to, the potential reclassification of cannabis to Schedule III in the United States, the potential benefits to Herbal Dispatch from such reclassification, the efforts and strategy of Herbal Dispatch to expand its business into US medical channels in the future, and the anticipated benefits of the DTC eligibility. The successful execution of these initiatives is subject to a number of risks and uncertainties, including industry competition, retention of key individuals, future customer demand for the Company's products, as well as market and investor participation, among others. Consequently, all of the forward-looking statements made in this news release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected effects on the Company. These forward-looking statements are made as of the date of this news release. Except as required by applicable securities legislation, the Company assumes no obligation to update publicly or revise any forward-looking statements to reflect subsequent information, events, or circumstances. THE CANADIAN SECURITIES EXCHANGE (THE "CSE") HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS NEWS RELEASE. NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/294309
Original: Herbal Dispatch Advances U.S. Strategy amid Historic Cannabis Rescheduling Shift

Herbal Dispatch Reports Q4 2025 Gross Sales of $6.2 Million, Achieves Positive Adjusted EBITDA, and Reports Full Year Gross Sales of $16.5 MillionApril 24, 2026 3:01 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - April 24, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), announces its financial results for the fourth quarter and year ended December 31, 2025.Q4 2025 HIGHLIGHTSGross sales of $6.2 million, representing a 115% increase compared to $2.9 million in Q4 2024Net revenue of $4.1 million (excluding excise taxes), up from $2.3 million in Q4 2024Adjusted EBITDA of $0.1 million, compared to $(0.6) million in Q4 2024Adjusted EBITDA of $0.2 million excluding non-recurring costs related to investor relations and financingFY 2025 HIGHLIGHTSGross sales of $16.5 million, representing a 37% increase compared to $12.1 million in 2024Net revenue of $12.1 million (excluding excise taxes), up from $9.9 million in 2024Adjusted EBITDA of $(0.7) million, improved from $(1.0) million in 2024Gross margin improved to approximately 22.7% in 2025, compared to 20.1% in 2024, reflecting enhanced cost of goods efficiency, improved product mix, and increasing scale across the Company's platform and the Company expects continued improvement into 2026 as scale and operating leverage continues to increase.STRATEGIC MOMENTUM Completed an oversubscribed non-brokered private placement, raising $2.1 million in October 2025Commenced trading on the OTCQB® Venture Market under the ticker LUFFF subsequent to year endFINANCIAL PERFORMANCEFor the three months ended December 31, 2025, gross sales increased by 115% to $6.2 million compared to $2.9 million in Q4 2024. Net revenue, excluding excise taxes, increased to $4.1 million compared to $2.3 million in the prior year quarter. The increase was driven by higher sales volumes across both medical and recreational channels and continued growth within the Company's e-commerce platform.As of this period, the Company's path to profitability is increasingly driven by expanding gross margins, with gross profit growing to $2.75 million in 2025 from $2.0 million in 2024, reflecting improved cost of goods sold efficiency and increasing operating leverage across the platform.Gross profit improved in Q4 2025 as a result of increased scale and improving operating efficiencies. Cost of goods sold as a percentage of sales declined year-over-year, reflecting enhanced purchasing power, optimized product mix, and improved supply chain execution. This expansion in gross margin is a key driver of the Company's path to sustained profitability and operating leverage.Adjusted EBITDA improved significantly in Q4 2025 to positive $0.1 million, compared to negative $0.6 million in Q4 2024, driven primarily by increased scale and improved gross margins. Excluding certain non-recurring investor relations costs and professional fees related to the October 2025 private placement, adjusted EBITDA for Q4 2025 would have been positive $0.2 million.For the full year ended December 31, 2025, adjusted EBITDA improved by 30% to negative $0.7 million compared to negative $1.0 million in 2024, reflecting continued progress toward profitability.MANAGEMENT COMMENTARY"The fourth quarter of 2025 marked a major step forward for Herbal Dispatch, as we delivered record quarterly gross sales and achieved positive adjusted EBITDA," said Philip Campbell, President & CEO of Herbal Dispatch. "We have now achieved double-digit growth for the third consecutive year, reflecting the strength of our platform, our customer relationships, and our ability to expand across both Canadian and international markets.""Looking ahead to 2026, our focus remains on scaling profitably, expanding our recreational footprint, growing medical sales-particularly among veterans-and accelerating export growth into federally legal international markets. With strong sales momentum and the added visibility of our OTCQB listing, we believe we are well-positioned to create long-term value for shareholders."CONSOLIDATED FINANCIAL STATEMENTSThe Company's consolidated financial statements and management's discussion & analysis for the year ended December 31, 2025 are available on the Company's profile on SEDAR+ at www.sedarplus.ca and will also be posted on the Company's website at www.herbaldispatch.com.ABOUT HERBAL DISPATCH INC.Herbal Dispatch Inc. is a leading operator of cannabis e-commerce platforms in Canada, delivering quality medical and recreational products to discerning consumers at competitive prices. Its flagship marketplace has earned trust as a premier destination for exclusive access to small-batch craft cannabis and a wide selection of curated cannabis products. The Company is also actively expanding through exports to international markets, positioning it for sustained growth and new revenue opportunities. The Company's common shares trade on the Canadian Securities Exchange under the symbol "HERB".For further information:
Philip Campbell, CEO and Director
Email: IR @Scotty-432-2420NON-IFRS MEASURES Adjusted EBITDA is defined as earnings before interest, income taxes, depreciation, amortization, share based compensation, loss (gain) on disposal of assets, loss (gain) on investments, loss (gain) on extinguishment of debt, impairment losses, loss (gain) on foreign exchange and accretion expense. The Company believes that, in addition to net income (loss), adjusted EBITDA is a useful measure as it provides an indication of the financial results generated by its principal business activities prior to consideration of how these activities are financed or how the results are taxed in various jurisdictions and before certain non-cash items such as depreciation, amortization, and other items. Adjusted EBITDA does not have any standardized meaning as prescribed by IFRS and therefore, is considered a non-IFRS measure and may not be comparable to similar measures presented by other issuers. A reconciliation of net loss to adjusted EBITDA for each of the periods presented in this news release follows:$
Three Months Ended

Year Ended


Dec 31
2025

Dec 31
2024

Dec 31
2025

Dec 31
2024













Net loss
(359,979)
(1,645,934)
(1,841,467)
(2,773,049)Add/subtract:
 

 

 

 
Interest
62,885

110,843

305,218

288,675
Impairment of investments
272,340

-

272,340

195,510
Share based compensation
(1,183)
31,766

94,646

42,591
Gain on settlement of debt
-

 

-

(19,912) Currency translation
-

820,310

-

820,310
(Gain) loss on foreign exchange
(734)
489

(95)
(10,966) Accretion expense
8,971

2,694

33,600

5,633
Depreciation & amortization
102,321

101,468

407,817

404,466


 

 

 

 
Adjusted EBITDA
84,621

(578,364)
(727,941)
(1,046,742) CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION:Certain statements in this news release, including statements or information containing terminology such as "anticipate", "believe", "intend", "expect", "estimate", "may", "could", "will", and similar expressions constitute "forward-looking statements" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, that address activities, events, or developments that the Company or a third party expect or anticipate will or may occur in the future, including the Company's future growth, results of operations, performance, and business prospects and opportunities are forward-looking statements. These forward-looking statements reflect the Company's current beliefs and are based on information currently available to the Company. These statements require the Company to make assumptions it believes are reasonable and are subject to inherent risks and uncertainties. Actual results and developments may differ materially from the anticipated results and developments discussed in the forward-looking statements as certain of these risks and uncertainties are beyond the Company's control. These risk factors are interdependent and the impact of any one risk or uncertainty on a particular forward-looking statement is not determinable. Examples of forward-looking statements in this news release and the key assumptions and risk factors involved in such statements include, but are not limited to, executing our strategic growth initiatives for 2026, which includes growing our medical sales to Veterans, expanding recreational sales and growing export sales. The successful execution of these initiatives is subject to a number of risks and uncertainties, including industry competition, and future customer demand for our products, among others.Consequently, all of the forward-looking statements made in this news release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected effects on the Company. These forward-looking statements are made as of the date of this news release. Except as required by applicable securities legislation, the Company assumes no obligation to update publicly or revise any forward-looking statements to reflect subsequent information, events, or circumstances. THE CANADIAN SECURITIES EXCHANGE (THE "CSE") HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS NEWS RELEASE. NEITHER THE CSE OR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/294073
Original: Herbal Dispatch Reports Q4 2025 Gross Sales of $6.2 Million, Achieves Positive Adjusted EBITDA, and Reports Full Year Gross Sales of $16.5 Million

Herbal Dispatch Welcomes the Honourable Herb Dhaliwal as Full-Time ChairmanApril 23, 2026 3:01 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - April 23, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a leading cannabis e-commerce and distribution platform, is pleased to announce the appointment of the Honourable Herb Dhaliwal, PC, as a full-time Board Member and Chairman of the Board.The Honourable Herb Dhaliwal, brings a wealth of experience in public service, business, and leadership to Herbal Dispatch. Mr. Dhaliwal is a former Member of Parliament for Vancouver South—Burnaby, and served in key federal cabinet positions, including as Minister of National Revenue, Minister of Natural Resources, and Minister of Fisheries and Oceans under Prime Minister Jean Chrétien. He was also a strong advocate within the Liberal government for the decriminalization of cannabis, contributing to early policy discussions that helped shape Canada's evolving regulatory landscape. His expertise in federal and provincial regulatory environments, and longstanding advocacy for cannabis reform make him exceptionally well-positioned to guide Herbal Dispatch through complex regulatory challenges and support its strategic growth across Canada and internationally."We are thrilled to welcome Herb Dhaliwal to our Board in a full-time capacity as Chairman," said Philip Campbell, CEO of Herbal Dispatch. "Mr. Dhaliwal's proven track record and high-level government experience will be instrumental in advancing our mission. His leadership and expertise will help accelerate Herbal Dispatch's expansion, strengthen our position in the Canadian cannabis market, enhance stakeholder value, and establish the Company as a frontrunner in the global cannabis sector.""I'm excited to continue serving Herbal Dispatch as Chairman and contribute to a company that is at the forefront of innovation in the cannabis sector," said Mr. Dhaliwal. "I look forward to leveraging my experience in public policy and international relations to help drive sustainable growth, navigate the regulatory landscape, and create lasting value for our customers, partners, and shareholders."This appointment reinforces Herbal Dispatch's governance and strategic oversight, enhancing the Company's ability to execute on international expansion while maintaining best-in-class standards in e-commerce, product quality, and customer experience.ABOUT HERBAL DISPATCH INC.Herbal Dispatch Inc. is a leading operator of cannabis e-commerce platforms in Canada, delivering quality medical and recreational products to discerning consumers at competitive prices. Its flagship marketplace has earned trust as a premier destination for exclusive access to small-batch craft cannabis and a wide selection of curated cannabis products. The Company is also actively expanding through exports to international markets, positioning it for sustained growth and new revenue opportunities. The Company's common shares trade on the Canadian Securities Exchange under the symbol "HERB".For further information, contact: Philip Campbell, CEO and Director
Email: IR @Scotty-432-2420CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION Certain statements in this news release, including statements or information containing terminology such as "anticipate", "believe", "intend", "expect", "estimate", "may", "could", "will", and similar expressions constitute "forward-looking statements" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, that address activities, events, or developments that the Company or a third party expect or anticipate will or may occur in the future, including the Company's future growth, results of operations, performance, and business prospects and opportunities are forward-looking statements. These forward-looking statements reflect the Company's current beliefs and are based on information currently available to the Company. These statements require the Company to make assumptions it believes are reasonable and are subject to inherent risks and uncertainties. Actual results and developments may differ materially from the anticipated results and developments discussed in the forward-looking statements as certain of these risks and uncertainties are beyond the Company's control. These risk factors are interdependent and the impact of any one risk or uncertainty on a particular forward-looking statement is not determinable. Consequently, all of the forward-looking statements made in this news release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected effects on the Company. These forward-looking statements are made as of the date of this news release. Except as required by applicable securities legislation, the Company assumes no obligation to update publicly or revise any forward-looking statements to reflect subsequent information, events, or circumstances. THE CANADIAN SECURITIES EXCHANGE (THE "CSE") HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS NEWS RELEASE. NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/293939
Original: Herbal Dispatch Welcomes the Honourable Herb Dhaliwal as Full-Time Chairman

Herbal Dispatch Announces Receipt of U.S. DTC Eligibility and Engagement of Market MakerApril 21, 2026 3:01 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - April 21, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a leading cannabis e-commerce and distribution platform, is pleased to announce that the Company's common shares are now eligible for electronic clearing and settlement through the Depository Trust Company ("DTC").DTC eligibility significantly enhances accessibility for U.S.-based investors by facilitating electronic trading, book-entry delivery, and depository services for the Company's shares. This improves liquidity and broadens exposure of the Company's stock within the North American investment community. DTC, a subsidiary of the Depository Trust & Clearing Corporation, manages the electronic clearing and settlement of publicly traded companies in the United States.This milestone complements the Company's primary listing on the Canadian Securities Exchange (CSE: HERB) and its Frankfurt Stock Exchange listing (FSE: HA9), as well as its trading on the U.S. OTCQB markets under the ticker symbol "LUFFF". The DTC eligibility is expected to improve liquidity and visibility for U.S.-based shareholders and positions the Company to capitalize on growing optimism in the American cannabis sector.Further, certain marketing partner agreements previously announced on December 11, 2025 have reached the end of their original terms and have been extended to June 30, 2026. The Company confirms that the capital allocated under these arrangements remains available and has not been deployed. Herbal Dispatch elected to defer campaign execution pending DTC eligibility.DTC eligibility is anticipated to facilitate improved access to the Company's securities for U.S. investors and support broader participation in trading. In anticipation of this development, the Company has completed planning for marketing initiatives and related infrastructure, positioning it to deploy previously allocated capital in a timely and measured manner following confirmation of DTC eligibility.The Company has engaged Independent Trading Group Inc., an arm's length service provider, to provide market making services in accordance with the policies of the Canadian Securities Exchange. The agreement provides for a monthly fee of $5,000. The Company and Trading Group Inc. are unrelated and unaffiliated entities. The engagement is intended to support liquidity, improve trading efficiency, and facilitate increased participation from U.S. investors following the Company's DTC eligibility.Shareholders and potential investors are encouraged to visit the Company's investor page at herbaldispatch.com/pages/investor for the latest updates, financial reports, and press releases.ABOUT HERBAL DISPATCH INC.Herbal Dispatch Inc. is a leading operator of cannabis e-commerce platforms in Canada, delivering quality medical and recreational products to discerning consumers at competitive prices. Its flagship marketplace has earned trust as a premier destination for exclusive access to small-batch craft cannabis and a wide selection of curated cannabis products. The Company is also actively expanding through exports to international markets, positioning it for sustained growth and new revenue opportunities. The Company's common shares trade on the Canadian Securities Exchange under the symbol "HERB".For further information contact: Philip Campbell, CEO and Director
Email: IR @Scotty-432-2420CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION Certain statements in this news release, including statements or information containing terminology such as "anticipate", "believe", "intend", "expect", "estimate", "may", "could", "will", and similar expressions constitute "forward-looking statements" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, that address activities, events, or developments that the Company or a third party expect or anticipate will or may occur in the future, including the Company's future growth, results of operations, performance, and business prospects and opportunities are forward-looking statements. These forward-looking statements reflect the Company's current beliefs and are based on information currently available to the Company. These statements require the Company to make assumptions it believes are reasonable and are subject to inherent risks and uncertainties. Actual results and developments may differ materially from the anticipated results and developments discussed in the forward-looking statements as certain of these risks and uncertainties are beyond the Company's control. These risk factors are interdependent and the impact of any one risk or uncertainty on a particular forward-looking statement is not determinable. Examples of forward-looking statements in this news release and the key assumptions and risk factors involved in such statements include, but are not limited to, the anticipated benefits of the DTC eligibility, the retention of key individuals to promote the success of the Company's business, as well as market and investor participation. The successful execution of these initiatives is subject to a number of risks and uncertainties, including industry competition, and future customer demand for the Company's products, among others. Consequently, all of the forward-looking statements made in this news release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected effects on the Company. These forward-looking statements are made as of the date of this news release. Except as required by applicable securities legislation, the Company assumes no obligation to update publicly or revise any forward-looking statements to reflect subsequent information, events, or circumstances. THE CANADIAN SECURITIES EXCHANGE (THE "CSE") HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS NEWS RELEASE. NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/293463
Original: Herbal Dispatch Announces Receipt of U.S. DTC Eligibility and Engagement of Market Maker

Waiting on DTC for US side but this company is doing everything right. Needs to get off Cse cesspool https://stockalpha.ai/herb/special-report.html

Herbal Dispatch Announces Extension of Convertible DebenturesFebruary 3, 2026 3:01 AM
NewsfileVancouver, British Columbia--(Newsfile Corp. - February 3, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a leading cannabis e-commerce and distribution platform, announces that is has amended the terms of the unsecured convertible debentures as entered into by the Company and each of 0971289 B.C. Ltd., a company controlled by Drew Malcolm ("Mr. Malcolm"), and Herb Dhaliwal ("Mr. Dhaliwal") on May 15, 2020, and December 13, 2023, respectively, as amended (collectively, the "Convertible Debentures").This final amendment to the Convertible Debentures extends the maturity date from January 31, 2026, to January 31, 2028 (the "Amendment"). All other terms of the Convertible Debentures remain the same with the: (a) interest rate being 14% per annum, the conversion price being CAD$0.06, and the threshold price being CAD$0.12. Prior to effecting the Amendment, the Company sought and obtained an exemption from the Canadian Securities Exchange (the "CSE") as it relates to certain requirements for convertible debenture amendments as provided for under Policy 6 "Distributions & Corporate Finance" of the CSE.Related Party TransactionAs both Mr. Malcolm and Mr. Dhaliwal are also directors of the Company, the Amendment constitute "related party transactions" for the purposes of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"). Under Sections 5.4 and 5.6 of MI 61-101, the Company is required to obtain a formal valuation and minority shareholder approval, respectively, for the Amendment unless exemptions are available.The Company is relying upon exemptions from the formal valuation and minority shareholder approval requirements of MI 61-101 pursuant to sections 5.5(a) and 5.7(1)(a), respectively, Fair Market Value Not More Than 25 Per Cent of Market Capitalization, on the basis that at the time the Amendment was agreed to, neither the fair market value of the subject matter of, nor the fair market value of the consideration for, the Amendment, insofar as it involves interested parties, exceeds 25 per cent of the Company's market capitalization.The Board of Directors of the Company have unanimously approved the Amendment, with each of Mr. Malcolm and Mr. Dhaliwal abstaining from the resolution approving the Amendment to their respective Convertible Debenture, and no materially contrary view, or abstention was expressed or made by any director in relation to the Amendment. The Company did not file a material change report in respect of the "related parties" participation in the Amendment at least 21 days before the effective date of the Amendment, as the parties were still in negotiation and discussions as it relates to the Amendment at that time.ABOUT HERBAL DISPATCH INC.Herbal Dispatch Inc. is a leading operator of cannabis e-commerce platforms in Canada, delivering quality medical and recreational products to discerning consumers at competitive prices. Its flagship marketplace has earned trust as a premier destination for exclusive access to small-batch craft cannabis and a wide selection of curated cannabis products. The Company is also actively expanding through exports to international markets, positioning it for sustained growth and new revenue opportunities. The Company's common shares trade on the Canadian Securities Exchange under the symbol "HERB".For further information:
Philip Campbell, CEO and Director
Email: IR @Scotty-432-2420CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATIONCertain statements in this news release, including statements or information containing terminology such as "anticipate", "believe", "intend", "expect", "estimate", "may", "could", "will", and similar expressions constitute "forward-looking statements" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, that address activities, events, or developments that the Company or a third party expect or anticipate will or may occur in the future, including the Company's future growth, results of operations, performance, and business prospects and opportunities are forward-looking statements.These forward-looking statements reflect the Company's current beliefs and are based on information currently available to the Company. These statements require the Company to make assumptions it believes are reasonable and are subject to inherent risks and uncertainties.Actual results and developments may differ materially from the anticipated results and developments discussed in the forward-looking statements as certain of these risks and uncertainties are beyond the Company's control. These risk factors are interdependent and the impact of any one risk or uncertainty on a particular forward-looking statement is not determinable. Consequently, all of the forward-looking statements made in this news release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected effects on the Company. These forward-looking statements are made as of the date of this news release. Except as required by applicable securities legislation, the Company assumes no obligation to update publicly or revise any forward-looking statements to reflect subsequent information, events, or circumstances.THE CANADIAN SECURITIES EXCHANGE (THE "CSE") HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS NEWS RELEASE. NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282416
Original: Herbal Dispatch Announces Extension of Convertible Debentures

LUFFF: effective Feb. 22,2024 a one for 10 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

Luff Enterprises Ltd. changed to Herbal Dispatch Inc.:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

Go Luff Go. On the comeback.

New company name why not change symbol

Why the change in symbol. I have followed this great company from the beginning.

Effective May 21,2021 PGTMF will change to LUFFF:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

Go luff go. Congrats on your recovering backs to profitability

What’s going on here. Share count ? Any reason to keep add to position ?

Ascent Industries Corp. changed to Luff Enterprises Ltd.

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

$PGTMF: CCAA Approval process


Currently at $0.032


GO $PGTMF


**************************************************


Ascent Obtains Court Approval of CCAA Plan and Announces Bi-Weekly Default Status Report
8:34 AM ET 12/20/19 | GlobeNewswire


Ascent Obtains Court Approval of CCAA Plan and Announces Bi-Weekly Default Status Report

VANCOUVER, British Columbia, Dec. 20, 2019 (GLOBE NEWSWIRE) -- Ascent Industries Corp. (CSE: ASNT) ("Ascent" or the "Company") is pleased to announce that the Company and certain of its affiliates obtained an order of the Supreme Court of British Columbia (the "Court") sanctioning and approving the Company's first amended and restated consolidated plan of compromise, arrangement and organization (the "Plan") under the Companies' Creditors Arrangement Act ("CCAA") at a hearing held on December 19, 2019.

The Court's sanction and approval of the Plan represents a key step towards the Company's implementation of the Plan. The Company is now diligently working towards satisfying the remaining conditions precedents to the Plan. The Company currently anticipates that the Plan will be implemented on or prior to December 30, 2019.

Copies of the Plan and other Court materials and information relating to the Plan and the CCAA proceedings are available on the website maintained by Ernst & Young Inc., the Court-appointed CCAA monitor, at www.ey.com/ca/ascent. All inquiries regarding the Company's proceedings under the CCAA should be directed to the Monitor by mail at Ernst & Young Inc., Pacific Centre, 700 West Georgia Street, P.O. Box 10101, Vancouver, British Columbia, Canada, V7Y 1C7, Attention: Jason Eckford, or by e-mail at jason.eckford@ca.ey.com.

BI-WEEKLY DEFAULT STATUS REPORT

The Company provides this default status report pursuant to National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults ("NP 12-203") and applicable policy of the British Columbia Securities Commission which applies to companies, such as Ascent, that are the subject of CCAA proceedings.

On May 16, 2019, the Company announced that its audited annual financial statements for the year ended December 31, 2018, including the related management discussion & analysis, and accompanying CEO and CFO certifications (collectively, the "Annual Filings") were not filed by the required filing deadline of April 30, 2019. As of the date hereof, the Company has not filed: (i) its interim financial statements for the three month period ended March 31, 2019 and related management discussion & analysis and accompanying CEO and CFO certifications; (ii) its interim financial statements for the three month period ended June 30, 2019 and related management discussion & analysis and accompanying CEO and CFO certifications; and (iii) its interim financial statements for the three month period ended September 30, 2019 and related management discussion & analysis and accompanying CEO and CFO certifications (collectively, the "Interim Filings") prior to the filing deadlines prescribed under National Instrument 51-102 -- Continuous Disclosure Obligations ("NI 51-102").

As previously reported, Ascent is currently involved in CCAA proceedings. Ascent is required to file bi-weekly default status reports in accordance with NP 12-203 until such time that the CCAA proceeding is concluded or until the defaults in filing the Annual Filings and Interim Filings are remedied.

The Company reports that there have been no material changes to the information contained in its last bi-weekly default status report dated December 2, 2019. Furthermore, there is no other material information concerning the affairs of the Company that has not been generally disclosed. The Company confirms that, since its last bi-weekly default status report dated December 2, 2019, there have been no failures by it in fulfilling its stated intentions with respect to satisfying the provisions of the alternative information guidelines under NP 12-203. The Company intends to file the Annual Filings and Interim Filings as soon as possible.

About Ascent Industries Corp.

The Company owns a commercial facility in Nevada, and various licenses in Nevada and Oregon. The Company is currently assessing various options in the health sciences and nutraceutical space.

THE CANADIAN SECURITIES EXCHANGE (THE "CSE") HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS PRESS RELEASE. NEITHER THE CSE OR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION:

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements include, but are not limited to, the anticipated completion and effective date of the Plan and the anticipated timing of the completion and filing of the Annual Filings and the Interim Filings. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, Ascent assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

For further information:

Paul Dillman

ir@ascentindustries.com

> Dow Jones Newswires

December 20, 2019 08:34 ET (13:34 GMT)